CCL2 - chemokine (C-C motif) ligand 2 Gene

Also Known as MCP-1

Species: Sus scrofa

Gene Type: protein coding
Gene ID: 397422

CCL2 Products (1)

mRNA Protein Name
NM_214214.1 NP_999379.1 C-C motif chemokine 2 precursor
Protein Preferred Names Protein Names

C-C motif chemokine 2

  • monocyte chemoattractant protein 1

  • monocyte chemotactic protein 1

  • small-inducible cytokine A2

Recombinant CCL2 Proteins

Cat. No. Product Name Accession Purity
HY-P700231AF Animal-Free MCP-1/CCL2 Protein, Pig (His) P42831 (Q24-P99) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (8)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0673 Pirfenidone Inhibitor 99.99% Yes
HY-B1322A Amodiaquine 99.92% Unkown
HY-B1322 Amodiaquine dihydrochloride dihydrate 99.97% Unkown
HY-B1203 Fludrocortisone 98.99% Yes
HY-B1322B Amodiaquine dihydrochloride 99.97% Unkown
HY-B0673R Pirfenidone (Standard) Inhibitor 99.97% Unkown
HY-B1076 Medrysone 99.79% Unkown
HY-B1203R Fludrocortisone (Standard) / Unkown

Clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Phase
HY-B0498 Bindarit Inhibitor 99.59% Phase 3
HY-148100A Emapticap pegol sodium Inhibitor 91.38% Phase 2
HY-148100 Emapticap pegol Inhibitor 91.38% Phase 2
HY-B0673S1 Deupirfenidone 99.93% Phase 2
Inhibitory Antibodies (3)
Cat. No. Product Name Effect
Purity Phase
HY-P99188 Carlumab Inhibitor 97.80% Phase 2
HY-P99450 Avdoralimab Inhibitor 99.25% Phase 2
HY-P99781 Plozalizumab Inhibitor 99.53% Phase 2

Pre-clinical Phase

Bioactive Molecules (42)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-W007376 Indole-3-carboxaldehyde 99.96% Unkown
HY-120501 B022 Inhibitor 99.27% Unkown
HY-115644 BMS-470539 dihydrochloride Agonist 99.85% Unkown
HY-120897 NS-3-008 hydrochloride Inhibitor 99.67% Unkown
HY-160552 244cis 99.67% Unkown
HY-116247 ST247 Agonist 99.88% Unkown
HY-N0444 Rubiadin 99.20% Unkown
HY-B0673S Pirfenidone-d5 Inhibitor 98.88% Unkown
HY-170415 EGR-1-IN-3 Inhibitor 99.13% Unkown
HY-W013675 2-Methoxyhydroquinone Pre-designed Set 99.57% Unkown
HY-NP192 Sericin 0% Unkown
HY-149202 UT-11 Inhibitor 98.25% Unkown
HY-P11553A ECL1i TFA Inhibitor 97.36% Unkown
HY-RS02089 CCL2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS16514 Ccl2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-B1203S Fludrocortisone-d5 / Unkown
HY-108554 Q94 hydrochloride Antagonist / Unkown
HY-121896 DSHN Activator / Unkown
HY-144334 CHIKV-IN-3 Inhibitor / Unkown
HY-163655 Glutaminyl Cyclase Inhibitor 6 Inhibitor / Unkown
HY-165528 Histamine glutarimide Inhibitor / Unkown
HY-171680 Anti-CCL2 (Carlumab)-SMCC-DM1 / Unkown
HY-171681 Anti-CCL2 (Carlumab)-SPDB-DM4 / Unkown
HY-171682 Anti-CCL2 (Carlumab)-McMMAF / Unkown
HY-171683 Anti-CCL2 (Carlumab)-VcMMAE / Unkown
HY-171684 Anti-CCL2 (Carlumab)-MC-Vc-PAB-SN38 / Unkown
HY-171685 Anti-CCL2 (Carlumab)-MC-Vc-PAB-DMEA-PEG2-Duocarmycin SA / Unkown
HY-171895 12-Nitrolinoleate / Unkown
HY-173518 SIN 14 / Unkown
HY-176255 TBK1 degrader-4 Inhibitor / Unkown
HY-178926 RAGE406R Inhibitor / Unkown
HY-180831 BRD4 D1-IN-3 Inhibitor / Unkown
HY-185153 MC-VC-PAB-DMEA-PEG2-Duocarmycin SA / Unkown
HY-B1203S1 Fludrocortisone-d2 / Unkown
HY-B1322AS1 Amodiaquine-d10 hydrochloride / Unkown
HY-N3887 Evoxine Inhibitor / Unkown
HY-P11553 ECL1i Inhibitor / Unkown
HY-W104821 Rosolic acid Activator / Unkown
HY-168782 Resolvin D2 n-3 DPA Inhibitor / Unkown
HY-174763 Human CCL2 mRNA / Unkown
HY-177933 mNOX-E36 Inhibitor / Unkown
HY-RS22945 Ccl2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Inhibitory Antibodies (4)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990297 Anti-Mouse/Rat/Human CCL2/MCP-1 Antibody (2H5) Inhibitor 99.5% Unkown
HY-P99149 Anti-Mouse TNFR2 Antibody (TR75-54.7) Inhibitor 98.864% Unkown
HY-P991280 BMS-981164 Inhibitor 95.36% Unkown
HY-P991208 Flt-3L-Ig (hum/hum) 98% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens CCL2 NCBI NCBI:6347